Anna S F Lok (Anna S Lok, Anna Lok, A S Lok, Anna Sf Lok)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 27

Top Topics

African American

Hepatitis B Virus

Roux En Y Gastric Bypass

Rheumatoid Arthritis Patients

Top Venues

Hepatology communications

JMIR formative research

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Anna S F Lok
Toward a Functional Cure for Hepatitis B. Gut and liver 18 (4) (2024)
Anna S F Lok
Toward a Functional Cure for Hepatitis B. Gut and liver 18 (4) (2024)
Anna S F Lok
Toward a Functional Cure for Hepatitis B. Gut and liver 18 (4) (2024)
Anna S F Lok
Toward a Functional Cure for Hepatitis B. Gut and liver (2024)
Anna S F Lok
Toward a Functional Cure for Hepatitis B. Gut and liver 18 (4) (2024)
Jacob V DiBattista, Anna S F Lok, Vincent L Chen
Long-term weight changes are associated with initial weight changes after nonalcoholic fatty liver disease diagnosis. Hepatology communications 7 (3) (2023)
Jeremy Louissaint, Jeffrey T Gibbs, Abhishek Shenoy, Shirley Cohen-Mekelburg, Anna S F Lok, Elliot B Tapper
Patient Portal Use and Risk of Readmissions in Decompensated Cirrhosis: Retrospective Study. JMIR formative research 7 (2023)
Matthew J Miller, Emily Harding-Theobald, Jacob V DiBattista, Zhe Zhao, Karn Wijarnpreecha, Anna S F Lok, Vincent L Chen
Progression to cirrhosis is similar among all ages in nonalcoholic fatty liver disease, but liver-related events increase with age. Hepatology communications 7 (6) (2023)
Jessica Leigh Mellinger, Sarah Medley, Kelley M Kidwell, Haila Asefah, Gerald Scott Winder, Anne C Fernandez, Anna S F Lok, Fred Blow
Improving alcohol treatment engagement using integrated behavioral interventions in alcohol-associated liver disease: A randomized pilot trial. Hepatology communications 7 (10) (2023)
Jeremy Louissaint, Jeffrey T Gibbs, Abhishek Shenoy, Shirley Cohen-Mekelburg, Anna S F Lok, Elliot B Tapper
Patient Portal Use and Risk of Readmissions in Decompensated Cirrhosis: Retrospective Study. JMIR formative research 7 (2023)
Jacob V DiBattista, Anna S F Lok, Vincent L Chen
Long-term weight changes are associated with initial weight changes after nonalcoholic fatty liver disease diagnosis. Hepatology communications 7 (3) (2023)
Wen-Juei Jeng, Anna S F Lok
What will it take to cure hepatitis B? Hepatology communications 7 (4) (2023)
Karn Wijarnpreecha, Anna S F Lok, Vincent L Chen
Editorial: clinical outcomes in lean NAFLD - the devil is in the details. Authors' reply. Alimentary pharmacology & therapeutics 57 (9) (2023)
Jeremy Louissaint, Jeffrey T Gibbs, Abhishek Shenoy, Shirley Cohen-Mekelburg, Anna S F Lok, Elliot B Tapper
Patient Portal Use and Risk of Readmissions in Decompensated Cirrhosis: Retrospective Study. JMIR formative research 7 (2023)
Jacob V DiBattista, Anna S F Lok, Vincent L Chen
Long-term weight changes are associated with initial weight changes after nonalcoholic fatty liver disease diagnosis. Hepatology communications 7 (3) (2023)
Wen-Juei Jeng, Anna S F Lok
What will it take to cure hepatitis B? Hepatology communications 7 (4) (2023)
Jacob V DiBattista, Anna S F Lok, Vincent L Chen
Long-term weight changes are associated with initial weight changes after nonalcoholic fatty liver disease diagnosis. Hepatology communications 7 (3) (2023)
Jeremy Louissaint, Jeffrey T Gibbs, Abhishek Shenoy, Shirley Cohen-Mekelburg, Anna S F Lok, Elliot B Tapper
Patient Portal Use and Risk of Readmissions in Decompensated Cirrhosis: Retrospective Study. JMIR formative research 7 (2023)
Karn Wijarnpreecha, Fang Li, Sori K Lundin, Deepika Suresh, Michael W Song, Cui Tao, Vincent L Chen, Anna S F Lok
Higher mortality among lean patients with non-alcoholic fatty liver disease despite fewer metabolic comorbidities. Alimentary pharmacology & therapeutics (2023)
Takeshi Yokoo, Nobuaki Masaki, Neehar D Parikh, Barton F Lane, Ziding Feng, Mishal Mendiratta-Lala, Chee Hwee Lee, Gaurav Khatri, Tracey L Marsh, Kirti Shetty, Colin T Dunn, Taim Al-Jarrah, Anum Aslam, Matthew S Davenport, Purva Gopal, Nicole E Rich, Anna S F Lok, Amit G Singal
Multicenter Validation of Abbreviated MRI for Detecting Early-Stage Hepatocellular Carcinoma. Radiology (2023)
Wen-Juei Jeng, Anna S F Lok
What will it take to cure hepatitis B? Hepatology communications 7 (4) (2023)
Jacob V DiBattista, Anna S F Lok, Vincent L Chen
Long-term weight changes are associated with initial weight changes after nonalcoholic fatty liver disease diagnosis. Hepatology communications 7 (3) (2023)
Patricia Pringle Bloom, Krishna Rao, Christine M Bassis, Borko Nojkov, Vincent B Young, Anna S F Lok
Regional changes in intestinal permeability in cirrhosis are associated with mucosal bacteria. Hepatology communications 7 (10) (2023)
Jeremy Louissaint, Jeffrey T Gibbs, Abhishek Shenoy, Shirley Cohen-Mekelburg, Anna S F Lok, Elliot B Tapper
Patient Portal Use and Risk of Readmissions in Decompensated Cirrhosis: Retrospective Study. JMIR formative research 7 (2023)
Wei Zhang, Grace L Su, Kaza Sravanthi, Rui Huang, Yi Wang, Huiying Rao, Lai Wei, Anna S F Lok
Metabolic abnormalities, liver and body fat in American versus Chinese patients with non-alcoholic fatty liver disease. JGH open : an open access journal of gastroenterology and hepatology 6 (8) (2022)
Mary J Thomson, Anna S F Lok, Elliot B Tapper
Appropriate and Potentially Inappropriate Medication Use in Decompensated Cirrhosis. Hepatology (Baltimore, Md.) 73 (6) (2021)
Anna S F Lok, L Ganova-Raeva, Y Cloonan, L Punkova, H-H S Lin, W M Lee, M G Ghany, null null
Prevalence of hepatitis B antiviral drug resistance variants in North American patients with chronic hepatitis B not receiving antiviral treatment. Journal of viral hepatitis 24 (11) (2017)